| EPC0339 | Causes of mortality among people living with HIV: preliminary results from a cross-sectional study at 29 health facilities in Uganda | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0340 | Magnitude and profile of HIV retesting in non-treatment naïve clients in Rwanda | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0341 | PrEP Equity by sex and age, United States, 2012-2021 | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0342 | Power analysis of PEPFAR's recency surveillance strategy: practical limitations of hotspot identification | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0343 | A force to reckon with: loss to follow up of children and adolescents in HIV care in Uganda, 2017 - 2021 | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0344 | Assessing 95-95-95 progress in cities across four regions | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0345 | Measuring HIV and hepatitis C incidence during the COVID-19 pandemic in a cohort of people who inject drugs | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0346 | Interest in and acceptability of dried blood spot (DBS) sampling in a bio-behavioural surveillance study among men who have sex with men in Aotearoa New Zealand | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0347 | Vertical transmission dynamics by age group – exploratory research findings from 9 Health Facilities in Mozambique | E-poster | Surveillance: Measuring the HIV epidemic |
| EPC0348 | Adherence is the key: targeting long-acting injectable cabotegravir to MSM current oral PrEP users with low adherence would be highly effective and efficient, a modelling study with Dutch perspectives | E-poster | Modelling the HIV epidemic |